| Literature DB >> 31766270 |
Sohye Kim1,2, Yong Seok Kwon3, Ju Young Kim4, Kyung Hee Hong5, Yoo Kyoung Park1.
Abstract
This study aimed to observe the relationship between iodine nutrition status (dietary iodine intake and estimated iodine intake based on urinary iodine concentration (UIC)) and thyroid disease-related hormones. This study involved 6090 subjects >19 years old with valid UIC, assessed between 2013 and 2015 by the Korean National Health and Nutrition Examination Survey, using a stratified, multistage, clustered probability-sampling design. The estimated iodine intake in participants was measured using UIC and urine creatinine. To examine the effect of iodine intake on thyroid disease, the iodine intake was divided into Korean Dietary Reference Intakes groups, and logistic regression analysis was performed via the surveylogistic procedure to obtain odds ratios (ORs) and 95% confidence intervals (CIs). The estimated iodine intake showed a significant positive correlation with dietary iodine intake (r = 0.021, p < 0.001), UIC (r = 0.918, p < 0.001), and thyroid-stimulating hormone (TSH) (r = 0.043, p < 0.001), but a significant negative correlation with free thyroxine (FT4) (r = -0.037, p < 0.001). Additionally, as the estimated iodine intake increased, age, TSH, and UIC increased, but FT4 decreased (p for trend < 0.0001). The risk of thyroid disease was higher in the "≥tolerable upper intake level (UL ≥ 2400 µg/day)" group than in the "<estimated average requirement (EAR < 150 µg/day)" group in females (OR: 2.418; 95% CI: 1.010-5.787). Also, as iodine intake increased, the risk of thyroid disease increased (p for trend < 0.038).Entities:
Keywords: Korean; epidemiologic studies; iodine nutrition status; thyroid disease; thyrotropin; urine iodine
Mesh:
Substances:
Year: 2019 PMID: 31766270 PMCID: PMC6893705 DOI: 10.3390/nu11112757
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Mean of dietary iodine intake vs. estimated iodine intake.
Iodine nutrition status of the subjects.
| Total ( | Unadjusted | Adjusted | Male ( | Unadjusted | Adjusted | Female ( | Unadjusted | Adjusted | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Thyroid Disease | Thyroid Disease | Non-Thyroid Disease | Thyroid Disease | Non-Thyroid Disease | Thyroid Disease ( | |||||||
| Mean ± SE | Mean ± SE | Mean ± SE | Mean ± SE | Mean ± SE | Mean ± SE | |||||||
| Dietary Iodine (μg/day) | 554.0 ± 35.8 | 458.8 ± 93.6 | 0.348 | 0.483 | 592.9 ± 60.0 | 533.2 ± 190.8 | 0.766 | 0.715 | 510.9 ± 34.3 | 445.8 ± 101.5 | 0.547 | 0.502 |
| Estimated Iodine (μg/day) | 780.0 ± 56.1 | 1108.1 ± 195.8 | 0.107 | 0.162 | 837.5 ± 97.8 | 775.7 ± 241.2 | 0.813 | 0.624 | 716.4 ± 39.0 | 1166.3 ± 226.2 | 0.051 | 0.067 |
| UIC c (μg/L) | 883.2 ± 92.1 | 1085.9 ± 183.9 | 0.322 | 0.400 | 913.5 ± 164.5 | 745.1 ± 235.8 | 0.558 | 0.462 | 849.8 ± 52.5 | 1145.5 ± 211.5 | 0.172 | 0.195 |
ap-value was calculated via the surveyreg procedure of SAS; b Adjusted for age and energy intake (energy intake was adjusted for age); c UIC = Urinary iodine concentration.
Figure 2TSH and FT4 of thyroid disease status by sex.
UIC, TSH, free T4, and KDRI of the estimated iodine intake by sex.
| Estimated Iodine Intake (µg/day) | Korean Dietary Reference Intakes (KDRI) | Unadjusted | Adjusted | |||
|---|---|---|---|---|---|---|
| <EAR a (<95) ( | ≥EAR, <RNI b (≥95, <150) ( | ≥RNI, <UL c (≥150, 2400) ( | ≥UL (≥2400) ( | |||
| Mean ± SE | Mean ± SE | Mean ± SE | Mean ± SE | |||
|
| ||||||
| Age | 44.3 ± 0.8 | 44.4 ± 0.6 | 46.8 ± 0.3 | 50.7 ± 0.9 | <.0001(+) | <.0001(+) |
| TSH (mIU/L) | 2.5 ± 0.1 | 2.5 ± 0.1 | 2.8 ± 0.1 | 3.7 ± 0.4 | 0.008(+) | 0.009(+) |
| UIC (μg/L) | 111.1 ± 2.6 | 168.5 ± 3.4 | 632.6 ± 13.6 | 6903.2 ± 1202.3 | <.0001(+) | <.0001(+) |
| FT4 (ng/dL) | 1.3 ± 0.01 | 1.3 ± 0.01 | 1.2 ± 0.005 | 1.2 ± 0.01 | <.0001(−) | <.0001(−) |
|
| ||||||
| Age | 41.7 ± 1.1 | 42.8 ± 0.8 | 45.6 ± 0.3 | 50.1 ± 1.1 | <.0001(+) | <.0001(+) |
| TSH (mIU/L) | 2.1 ± 0.1 | 2.3 ± 0.1 | 2.6 ± 0.1 | 4.0 ± 0.7 | 0.024(+) | 0.024(+) |
| UIC (μg/L) | 109.8 ± 3.5 | 154.8 ± 3.9 | 580.0 ± 15.4 | 7404.0 ± 2222.9 | 0.002(+) | 0.002(+) |
| FT4 (ng/dL) | 1.3 ± 0.01 | 1.3 ± 0.0 | 1.3 ± 0.01 | 1.2 ± 0.02 | <.0001(−) | 0.002(−) |
|
| ||||||
| Age | 46.0 ± 0.9 | 45.9 ± 0.8 | 48.3 ± 0.4 | 51.3 ± 1.3 | 0.002(+) | 0.003(+) |
| TSH (mIU/L) | 2.8 ± 0.1 | 2.8 ± 0.1 | 3.1 ± 0.1 | 3.4 ± 0.2 | 0.062(+) | 0.079(+) |
| UIC (μg/L) | 112.0 ± 3.3 | 181.6 ± 5.2 | 694.9 ± 21.6 | 6350.5 ± 597.7 | <.0001(+) | <.0001(+) |
| FT4 (ng/dL) | 1.2 ± 0.01 | 1.2 ± 0.01 | 1.2 ± 0.01 | 1.1 ± 0.01 | 0.0001(−) | 0.001(−) |
a EAR: Estimated average requirement; b RNI: Recommended nutrient intake; c UL: Tolerable upper intake; d All p for trend were calculated by surveyreg procedure of SAS; e Adjusted for age and energy intake (age was adjusted for energy intake).
Figure 3Correlation of TSH and age with the estimated iodine intake.
Figure 4Correlation of UIC and free thyroxine (FT4) with the estimated iodine intake.
Prevalence of thyroid disease, intake range, median, and mean according to the KDRI of the estimated iodine intake by sex.
| Estimated Iodine Intake (µg/day) | Korean Dietary Reference Intake (KDRI) a | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| <EARc (<95) | ≥EAR, <RNI d | ≥RNI, <UL e | ≥UL | Total | |||||
| Total | |||||||||
| Intake Range | 1.29–94.99 | 95.01–149.95 | 150.02–2399.36 | 2409.77–80672.0 | 1.29–80672.0 | ||||
| Median ± SE b | 72.0 ± 1.2 | 122.5 ± 1.1 | 362.5 ± 7.1 | 4102.9 ± 152.3 | 256.4 ± 5.5 | ||||
| Mean ± SE | 69.4 ± 0.8 | 122.2 ± 0.6 | 558.0 ± 9.7 | 6301.4 ± 672.7 | 790.1 ± 54.7 | ||||
|
| |||||||||
| Non-Thyroid Disease | 830 | 97.2 | 964 | 97.6 | 3744 | 96.9 | 370 | 94.4 | 5908 |
| Thyroid Disease | 20 | 2.8 | 23 | 2.4 | 125 | 3.1 | 19 | 5.6 | 187 |
|
| |||||||||
| Intake Range | 2.79–94.99 | 95.03–149.76 | 150.02–2391.91 | 2414.16–80672.0 | 2.79–80672.0 | ||||
| Median ± SE | 74.6 ± 1.7 | 122.0 ± 1.4 | 355.7 ± 8.3 | 3823.3 ± 227.3 | 270.9 ± 6.5 | ||||
| Mean ± SE | 71.7 ± 1.2 | 122.1 ± 0.9 | 543.5 ± 12.8 | 6772.6 ± 1228.9 | 836.9 ± 96.9 | ||||
|
| |||||||||
| Non-Thyroid Disease | 293 | 98.2 | 449 | 99.1 | 1894 | 99.2 | 191 | 99.3 | 2827 |
| Thyroid Disease | 3 | 1.8 | 4 | 0.9 | 16 | 0.8 | 2 | 0.7 | 25 |
|
| |||||||||
| Intake Range | 1.29–94.97 | 95.01–149.95 | 150.29–2399.36 | 2409.77–36494.0 | 1.29–36494.0 | ||||
| Median ± SE | 70.3 ± 1.6 | 122.7 ± 1.8 | 372.8 ± 12.7 | 4285.4 ± 189.5 | 235.4 ± 8.1 | ||||
| Mean ± SE | 67.9 ± 1.0 | 122.3 ± 0.9 | 575.3 ± 13.7 | 5781.4 ± 399.6 | 740.7 ± 38.7 | ||||
|
| |||||||||
| Non-Thyroid Disease | 537 | 96.4 | 515 | 96.1 | 1850 | 94.2 | 179 | 89.0 | 3081 |
| Thyroid Disease | 17 | 3.6 | 19 | 3.9 | 109 | 5.8 | 17 | 11.0 | 162 |
a KDRI group was classified based on the estimated iodine intake; b Standard error; c EAR: estimated average requirement; d RNI: Recommend nutrient intake; e UL: Tolerable upper intake.
Figure 5Population distribution of iodine intake by KDRI in the total subjects.
Logistic regression analysis of thyroid disease across KDRI of the estimated iodine intake by sex.
| Estimated Iodine Intake | Korean Dietary Reference Intake (KDRI) | ||||
|---|---|---|---|---|---|
| <EAR a | ≥EAR, <RNI b | ≥RNI, <UL c | ≥UL (≥2400) | ||
|
| |||||
| Model 1 | 1 e | 0.832(0.409–1.692) f | 1.084(0.634–1.854) | 1.788(0.820–3.898) | 0.059(+) |
| Model 2 | 1 | 0.854(0.416–1.750) | 1.092(0.631–1.891) | 1.692(0.773–3.704) | 0.096(+) |
| Model 3 | 1 | 0.887(0.428–1.838) | 1.144(0.657–1.992) | 1.796(0.815–3.960) | 0.076(+) |
| Model 4 | 1 | 0.891(0.422–1.882) | 1.166(0.662–2.056) | 1.846(0.840–4.058) | 0.066(+) |
| Model 5 | 1 | 0.847(0.390–1.836) | 1.095(0.612–1.957) | 1.726(0.760–3.923) | 0.085(+) |
|
| |||||
| Model 1 | 1 | 0.499(0.095–2.620) | 0.440(0.108–1.792) | 0.414(0.051–3.359) | 0.720(−) |
| Model 2 | 1 | 0.474(0.089–2.528) | 0.390(0.095–1.609) | 0.325(0.041–2.568) | 0.607(−) |
| Model 3 | 1 | 0.397(0.075–2.098) | 0.317(0.073–1.378) | 0.251(0.034–1.839) | 0.549(−) |
| Model 4 | 1 | 0.405(0.080–2.054) | 0.353(0.079–1.566) | 0.278(0.036–2.161) | 0.582(−) |
| Model 5 | 1 | 0.419(0.084–2.084) | 0.311(0.070–1.378) | 0.240(0.029–1.954) | 0.5573(−) |
|
| |||||
| Model 1 | 1 | 1.056(0.492–2.263) | 1.667(0.908–3.061) | 2.940(1.267–6.823) | 0.014(+) |
| Model 2 | 1 | 1.054(0.490–2.267) | 1.629(0.887–2.989) | 2.773(1.198–6.420) | 0.023(+) |
| Model 3 | 1 | 1.063(0.488–2.315) | 1.608(0.873–2.961) | 2.686(1.161–6.215) | 0.026(+) |
| Model 4 | 1 | 1.048(0.479–2.292) | 1.561(0.846–2.881) | 2.554(1.113–5.861) | 0.034(+) |
| Model 5 | 1 | 0.979(0.438–2.192) | 1.426(0.766–2.654) | 2.418(1.010–5.787) | 0.038(+) |
a KDRI group was classified based on the estimated iodine intake; b Standard error; c EAR: Estimated average requirement; d p for trend was calculated by surveylogistic procedure of SAS; e Reference; f Odds ratio (95% CI, confidence interval); Model 1: Unadjusted model; Model 2: Adjusted for age and energy intake; Model 3: Adjusted for age, energy intake, weight status, exercise status, smoking status, and alcohol consumption; Model 4: Adjusted for age, energy intake, weight status, exercise status, smoking status, alcohol consumption, breakfast, and frequency of eating out; Model 5: Adjusted for age, energy intake, weight status, exercise status, smoking status, alcohol consumption, breakfast, frequency of eating out, education level, region of residence, household income level, and occupation.
Figure 6The odds ratio for thyroid disease by the estimated iodine intake in female.